Mimedx (MDXG) Share-based Compensation (QoQ) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Mimedx | 530.69 Mn | 370.92 Mn | 41.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -168.86% |
| Dec 31, 2025 | -49.93% |
| Sep 30, 2025 | 3.51% |
| Jun 30, 2025 | 11.50% |
| Mar 31, 2025 | -9.18% |
| Dec 31, 2024 | 23.21% |
| Sep 30, 2024 | -6.89% |
| Jun 30, 2024 | -5.74% |
| Mar 31, 2024 | -1.05% |
| Dec 31, 2023 | -0.05% |
| Sep 30, 2023 | 8.08% |
| Jun 30, 2023 | 4.00% |
| Mar 31, 2023 | 636.60% |
| Dec 31, 2022 | -77.66% |
| Sep 30, 2022 | -46.43% |
| Jun 30, 2022 | 10.76% |
| Mar 31, 2022 | 31.47% |
| Dec 31, 2021 | -20.20% |
| Sep 30, 2021 | -6.13% |
| Jun 30, 2021 | 25.15% |
| Mar 31, 2021 | -16.93% |
| Dec 31, 2020 | 6.43% |
| Sep 30, 2020 | -17.25% |
| Jun 30, 2020 | 32.40% |
| Mar 31, 2020 | 16.89% |
| Dec 31, 2019 | 6.66% |
| Sep 30, 2019 | -23.24% |
| Jun 30, 2019 | 16.09% |
| Mar 31, 2019 | 106.86% |
| Dec 31, 2018 | -63.19% |
| Sep 30, 2018 | -10.49% |
| Jun 30, 2018 | -10.32% |
| Mar 31, 2018 | -17.31% |
| Dec 31, 2017 | 12.38% |
| Sep 30, 2017 | 0.97% |
| Jun 30, 2017 | 12.50% |
| Mar 31, 2017 | 19.59% |
| Dec 31, 2016 | -16.93% |
| Sep 30, 2016 | 4.28% |
| Jun 30, 2016 | -2.30% |
| Mar 31, 2016 | 6.53% |
| Dec 31, 2015 | -1.05% |
| Sep 30, 2015 | 2.94% |
| Jun 30, 2015 | 8.14% |
| Mar 31, 2015 | 19.47% |
| Dec 31, 2014 | 8.93% |
| Sep 30, 2014 | 9.22% |
| Jun 30, 2014 | 16.65% |
| Mar 31, 2014 | 27.87% |
| Dec 31, 2013 | 11.23% |
| Sep 30, 2013 | 11.00% |
| Jun 30, 2013 | 52.56% |
| Mar 31, 2013 | 25.72% |
| Dec 31, 2012 | 17.01% |
| Sep 30, 2012 | 14.40% |
| Jun 30, 2012 | 16.81% |
| Mar 31, 2012 | -20.08% |
| Dec 31, 2011 | 181.35% |
| Sep 30, 2011 | -48.08% |
| Jun 30, 2011 | 12.81% |